EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland

Tuire Prami iD, Mari Pölkki iD, Jarno Ruotsalainen iD, Elin Banke Nordbeck, Susanna Meyner iD, Ari Kaski

Nordic Studies on Alcohol and Drugs · 2024-04 · 41 (2) · 200-211

DOI: 10.1177/14550725231204723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nordic Studies on Alcohol and Drugs, online erschienen am 17.10.2023. Verfasst von Tuire Prami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oriola, Espoo, Finland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Camurus AB, Lund, Sweden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To characterise and understand the untreated high-risk opioid user population in Finland, and to determine the reasons why these people do not enter treatment.

Methods

The study setting was a half-year cross-sectional survey in Finland during 2021–2022. An electronic questionnaire with 24 structured questions was concluded in 16 needle exchange units. Participants were opioid-dependent people without opioid agonist treatment (OAT), and they answered the survey voluntarily and anonymously.

Results

Of the 167 respondents, 62% were men, 53% were aged ≤34 years, 66% had used opioids for >6 years, and 78% used drugs intravenously (IV) daily. The most used opioid (95%) was buprenorphine. Most respondents used opioids as self-medication for withdrawal symptoms (75%), or to treat psychological symptoms (59%) or pain (43%). Of them, 70% also used other substances for recreational purposes. The most common named reasons to stay outside OAT were as follows: seeking treatment is too difficult (37%); treatment is too binding (36%); and fear of actions from authorities (23%).

Conclusions

For opioid-dependent respondents who would be eligible for OAT in Finland, treatment awareness is limited. These high-risk opioid users also think that the treatment would be too binding. In conclusion, there is a need for increase in general information about, accessibility to, acceptance for and individualisation of OAT.

Schlagwörter

Stichwörter der Autor:innen

buprenorphinehigh-risk opioid useintravenous opioid useopioid agonist treatmentopioid dependence

Autor:innen und Institutionen

  • Oriola, Espoo, Finland.
  • Camurus AB, Lund, Sweden.
  • Kuopio Addiction Medicine Center, Kuopio, Finland.

ORCID-Profile: Tuire Prami, Mari Pölkki, Jarno Ruotsalainen, Susanna Meyner

Förderung

  • Camurus AB, Lund, Sweden

Zitieren

APA

Prami, T., Pölkki, M., Ruotsalainen, J., Nordbeck, E. B., Meyner, S., & Kaski, A. (2024). Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland. Nordic Studies on Alcohol and Drugs, 41(2), 200-211. https://doi.org/10.1177/14550725231204723

Vancouver

Prami T, Pölkki M, Ruotsalainen J, Nordbeck EB, Meyner S, Kaski A. Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland. Nordic Studies on Alcohol and Drugs. 2024;41(2):200-211. doi:10.1177/14550725231204723

BibTeX
@article{Prami2024,
  author = {Prami, Tuire and Pölkki, Mari and Ruotsalainen, Jarno and Nordbeck, Elin Banke and Meyner, Susanna and Kaski, Ari},
  title = {Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland},
  journal = {Nordic Studies on Alcohol and Drugs},
  year = {2024},
  volume = {41},
  number = {2},
  pages = {200--211},
  doi = {10.1177/14550725231204723}
}
Kostenlos starten →